Planned Akamai (NASDAQ: AKAM) CFO stock sale totals 13,745 shares

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Akamai Technologies’ Chief Financial Officer Edward J. McGowan reported open‑market sales of a total of 13,745 shares of common stock on March 10, 2026, in two transactions at weighted average prices of $100.9678 and $101.7462 per share.

The filing states these sales were made under a pre‑arranged Rule 10b5‑1 trading plan adopted on September 4, 2025. After the sales, McGowan held 38,784 shares directly, plus 124.961 shares indirectly through a 401(k) plan as of March 9, 2026, with total beneficial ownership including 29,800 deferred shares.

Insights

Planned, open‑market CFO stock sale looks routine in scale.

CFO Edward J. McGowan sold 13,745 Akamai shares in open‑market transactions on March 10, 2026, at weighted average prices just above $100 per share. The transactions are coded as standard sales of common stock.

A key detail is that the filing specifies the sales occurred under a Rule 10b5‑1 trading plan adopted on September 4, 2025. Such plans pre‑schedule trades, reducing the informational value of the exact timing because decisions were made well before the trade date.

Post‑transaction, McGowan directly owns 38,784 shares and has additional indirect and deferred holdings, indicating he retains a meaningful equity stake. Given the pre‑planned nature and remaining ownership, this looks like a routine liquidity event rather than a thesis‑changing move.

Insider Trade Summary 10b5-1

Net Seller: 13,745 shares ($1,390,925)

Net Sell 3 txns

Insider McGowan Edward J

Role Chief Financial Officer

Sold 13,745 shs ($1.39M)

Type	Security	Shares	Price	Value
Sale	Common Stock	9,734	$100.9678	$983K
Sale	Common Stock	4,011	$101.7462	$408K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 42,795 shares (Direct); Common Stock — 124.961 shares (Indirect, By 401(k) Plan)

Footnotes (1)

Sale was made pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 4, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.485 to $101.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Total shares beneficially owned includes 29,800 shares of which the Reporting Person has elected to defer receipt pursuant to the Akamai Technologies, Inc. Amended and Restated U.S. Non-Qualified Deferred Compensation Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.52 to $101.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. As of March 9, 2026.

Form 4 Insider Transactions: What Each Field Means →

03/10/2026 - 04:13 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McGowan Edward J

(Last)

(First)

(Middle)

C/O AKAMAI TECHNOLOGIES, INC.

145 BROADWAY

(Street)

CAMBRIDGE

02142

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
AKAMAI TECHNOLOGIES INC [ AKAM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/10/2026		S⁽¹⁾		9,734	D	$100.9678⁽²⁾	42,795⁽³⁾	D
Common Stock	03/10/2026		S⁽¹⁾		4,011	D	$101.7462⁽⁴⁾	38,784⁽³⁾	D
Common Stock								124.961⁽⁵⁾	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Sale was made pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 4, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.485 to $101.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Total shares beneficially owned includes 29,800 shares of which the Reporting Person has elected to defer receipt pursuant to the Akamai Technologies, Inc. Amended and Restated U.S. Non-Qualified Deferred Compensation Plan.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.52 to $101.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. As of March 9, 2026.

Remarks:

	/s/ Thomas M. Lair, as power of attorney	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Akamai (AKAM) disclose for its CFO?

Akamai disclosed that CFO Edward J. McGowan sold 13,745 shares of common stock in open‑market transactions on March 10, 2026. The shares were sold in two tranches at weighted average prices of $100.9678 and $101.7462 per share.

Were Edward McGowan’s Akamai stock sales under a Rule 10b5-1 plan?

Yes. The filing states the sale was made pursuant to a Rule 10b5‑1 trading plan adopted by Edward J. McGowan on September 4, 2025. Such pre‑arranged plans schedule trades in advance to reduce concerns about trading on non‑public information.

How many Akamai shares does the CFO hold after the reported sales?

After the reported sales, Edward J. McGowan holds 38,784 Akamai common shares directly. He also has 124.961 shares held indirectly through a 401(k) plan as of March 9, 2026, and total beneficial ownership includes 29,800 shares deferred under a compensation plan.

What prices did the Akamai CFO receive for the shares sold?

The filing reports weighted average sale prices of $100.9678 and $101.7462 per share. Footnotes explain these averages reflect multiple trades in ranges from $100.485 to $101.45 and from $101.52 to $101.99, respectively, across the sale transactions.

Does the Akamai Form 4 indicate any derivative exercises by the CFO?

No derivative exercises are shown in this Form 4. All reported transactions involve non‑derivative common stock sales and an updated holding entry. The derivativeSummary section in the data is empty, indicating no option or other derivative transactions were reported in this filing.

How significant is the Akamai CFO’s stock sale relative to his remaining holdings?

The CFO sold 13,745 shares but still directly owns 38,784 shares, plus indirect and deferred holdings. This means he retains a substantial stake in Akamai. Combined with the pre‑planned Rule 10b5‑1 structure, the sale appears consistent with routine portfolio management.